Autopsy report · NCT03820544
SEMS Placement Before Surgery in Unblocking Bile Duct in Patients With Periampullary Pancreatic Cancer With Severe Obstructive Jaundice
Cause of deathSlow enrollment
“Interest in this study changed and it was decided to end enrollment early”
Life of this trial
- Registered 1 year 5 months after it had already started.
- Ran for about 1 year 7 months before it stopped.
- 4 participants enrolled.
- Results were posted on the registry 6 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
- Sponsor type
- University, hospital or other
- Conditions
- Pancreatic Cancer
- Interventions
- Endoscopic Retrograde Cholangiopancreatography; Standard of care
- Participants
- 4
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Effect of Fish Oil (Omega-3 Fatty Acids) on Arteries
“The study was discontinued early due to lack of funding and slow enrollment” - Tracking Biomarkers of Speech Intelligibility
“Funding for this study ended prior to enrollment of any participants due to a change in funding.” - Adagrasib in Combination With BI 1701963 in Patients With Cancer (KRYSTAL 14)
“The decision was made to terminate this study to further enrollment, as of 08 March 2022. The decision was made primarily due to a change in development strategy.” - Salvage Cryotherapy in Recurrent Prostate Cancer
“Study was ended due to low enrollment” - Concurrent Nab-P/Carboplatin and Thoracic Radiotherapy in Squamous Cell Lung Cancer
“The study was halted because enrollment was too slow”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.